The U.S. Centers for Medicare & Medicaid Services (CMS) assigned a unique Healthcare Common Procedure Coding System (HCPCS) code or J-Code to Fidia Pharma’s HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. The reimbursement code is effective January 2017.
The product was launched in the U.S. at AAOS 2016.
The U.S. Centers for Medicare & Medicaid Services (CMS) assigned a unique Healthcare Common Procedure Coding System (HCPCS) code or J-Code to Fidia Pharma's HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. The reimbursement code is effective January 2017.
The product was launched in the U.S. at AAOS...
The U.S. Centers for Medicare & Medicaid Services (CMS) assigned a unique Healthcare Common Procedure Coding System (HCPCS) code or J-Code to Fidia Pharma’s HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. The reimbursement code is effective January 2017.
The product was launched in the U.S. at AAOS 2016.
Copy to clipboard 
